News Quantified

CODX – co-diagnostics, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Co-Diagnostics (NASDAQ:CODX) was downgraded by analysts at Wall Street Z

Co-Diagnostics (NASDAQ:CODX) had its "hold" rating reaffirmed by analysts at Maxim Group.

-14.0%

BEAT

10.9%

BEAT

-4.3%

BEAT

Form SCHEDULE 13G/A Co-Diagnostics, Inc. Filed by: Ayrton Capital LLC

Form S-8 Co-Diagnostics, Inc.

Form 8-K Co-Diagnostics, Inc. For: Jan 07

Form 8-K Co-Diagnostics, Inc. For: Dec 29

Form 424B5 Co-Diagnostics, Inc.

Top News Gainers

3/10 Co-Diagnostics down 39% on proliferation of COVID-19 competitors [Seeking Alpha] 89.0%

1/23 Co-Diagnostics, Inc. Designs Test for New Coronavirus Using CoPrimer™ Platform 79.6%

1/27 Vaccine, diagnostics stocks rise again on spreading coronavirus [MarketWatch] 38.1%

2/28 Form 424B5 Co-Diagnostics, Inc. 35.0%

4/16 Co-Diagnostics, Inc. COVID-19 Test Technology Validated for Use on Saliva Samples 30.6%

2/10 Co-Diagnostics, Inc. Announces Sales of New Coronavirus Test 28.2%

7/18 Co-Diagnostics Inc CoPrimers Provide High-Performance Detection of Cancer Mutations in Liquid Biopsy Samples 26.4%

2/6 Co-Diagnostics, Inc. Announces Launch of Test for New Coronavirus 24.2%

2/24 Co-Diagnostics, Inc. Receives CE Mark for Novel Coronavirus Test 20.2%

1/31 Coronavirus update: 213 dead, more countries recommending against China travel [MarketWatch] 19.4%

Top News Decliners

2/28 Why Acquisition & Coordination of First Responders Data On COVID-19 Becoming Critically Essential -34.3%

3/9 Co-Diagnostics Inc (NASDAQ: CODX) had its price target raised by analysts at HC Wainwright from $4.00 to $20.00. They now have a "buy" rating on the stock. -28.8%

3/12 Global Response to the COVID-19 Outbreak Intensifies -25.6%

1/27 Form 424B5 Co-Diagnostics, Inc. -23.6%

2/10 Co-Diagnostics up 36% on coronavirus test sales [Seeking Alpha] -19.7%

1/31 Coronavirus update: Trump declares coronavirus a public health emergency, U.S. citizens returning from Hubei Province to be quarantined [MarketWatch] -18.5%

3/2 Co-Diagnostics CEO on FDA's coronavirus policy changes [Yahoo! Finance News] -18.4%

3/3 Faulty COVID-19 Test Kits Tilt Scales in Coronavirus's Favor [The Motley Fool] -13.7%

3/17 Co-Diagnostics says new FDA policy to help expand use of COVID-19 test [Reuters (UK)] -13.5%

2/18 Co-Diagnostics (NASDAQ:CODX) Helping to Mitigate Global Economic Risk -12.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day